Funding Opportunities for Cardiovascular Disease and Diabetes Research

Overview

Date: Thursday, April 4
Time: 12:00 p.m. ET

Description:

The ADA Diabetes and Cardiovascular Disease is honored to have Dr. Nicole Redmond from the NIH/NHLBI, Dr. Elizabeth Cooper-Reelhorn from AHA and Dr. John Rosen from JDRF to share current grant funding opportunities at the NIH/NHLBI, AHA and the JDRF and their visions on future research focuses related to diabetes and cardiovascular disease at these three agencies. Researchers at all stages of their careers are welcome.

Learning Objectives:

Understand the current landscape of research funding for cardiovascular disease and diabetes.
Learn about the various funding sources available for researchers.
Gain insights into the priorities and criteria of funding agencies in the area of cardiovascular disease and diabetes.

Moderator

Richard Pratley, MD
Associate Medical Director of Research and Education,
AdventHealth
Diabetes Institute

Dr. Pratley is board certified in internal medicine and serves as the Associate Medical Director of Research and Education at the AdventHealth Diabetes Institute. He is also Senior Investigator and Diabetes Program Lead at the Translational Research Institute for Metabolism and Diabetes. He is a member of the editorial boards of The Lancet: Diabetes and Endocrinology, The Journal of Clinical Endocrinology and Metabolism, The Journal of Diabetes and Complications, and Reviews of Diabetes Studies. As an internationally recognized expert in diabetes, he has conducted numerous research studies on the pathogenesis, prevention, and treatment of diabetes. He and the specialists at Florida Diabetes and Endocrine Center provide compassionate care with a focus on healthy lifestyles and the prevention of complications related to diabetes. From outpatient medical evaluation and treatment to advanced diabetes education and research studies, Dr. Pratley partners with primary care physicians to provide state-of-the-art, evidence-based care for an array of conditions.

Speakers

	Nicole Redmond, MD, PhD, MPH (NIH/NHLBI) Chief, Clinical Applications and Prevention Branch (CAPB) Division of Cardiovascular Sciences (DCVS) National Heart, Lung, and Blood Institute (NHLBI) Nicole Redmond, MD, PhD, MPH is currently Chief of the Clinical Applications and Prevention Branch within the Division of Cardiovascular Sciences (DCVS) at the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH). As a medical officer in the Branch since 2016, Dr. Redmond has developed an extensive portfolio of clinical research, particularly clinical trials, in cardiovascular disease (CVD) prevention and treatment. She has interests in community engagement to enhance equity in clinical research participation and addressing structural and social determinants of health to mitigate health disparities. She also has a strong commitment to mentoring and career development, particularly for clinician-scientists and groups underrepresented in biomedical research as evidenced in her involvement and leadership in the NIH Pathways Summer Internship Program, Research in Residency program, and now as the Program Official for the NHLBI Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE) program. She has advanced the interests of CAPB, DCVS, and NHLBI through her participation and leadership in several NIH-wide initiatives including the cardiovascular disease portfolio supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Special Diabetes Program, the All of Us Research Program, and most recently co-chairs the Office of Disease Prevention ADVANCE: Advancing Prevention Research for Health Equity Cardiometabolic working group. Dr. Redmond actively participates in national and local networks of other clinicians and researchers involved in research, teaching, and clinical care focused on eliminating health disparities. She is also a Fellow of the American College of Physicians and a member of the American Heart Association. Dr. Redmond’s involvement in these organizations facilitates her capability to disseminate research findings and innovations in practice among leaders and stakeholders nationally. Prior to joining NHLBI as a Medical Officer in CAPB in 2016, Dr. Redmond was Assistant Professor in the Division of Preventive Medicine in the School of Medicine at the University of Alabama at Birmingham (UAB). She is a board-certified internal medicine physician who completed her MD/PhD in the Medical Scientist Training Program (MSTP) at the Medical University of South Carolina (MUSC) in Charleston, South Carolina. She completed her internal medicine (primary care track) residency at Emory University in Atlanta, Georgia which included training at the Atlanta VA Medical Center and Grady Health System. She received her Masters in Public Health from Harvard School of Public Health as a part of her training in the Harvard Fellowships in General Internal Medicine and Primary Care at Brigham and Women’s Hospital in Boston, Massachusetts.
	Elizabeth M. Cooper-Reelhorn National Senior Research Administrator Office of Science Operations American Heart Association (AHA) Elizabeth M. Cooper-Reelhorn is a National Senior Research Administrator and long-time staff member at the American Heart Association (AHA). The AHA, is a leading nonprofit organization in cardiovascular and cerebral vascular research. Over its history, the AHA has invested more than $5.7 billion in funding research endeavors since its inception in 1949. With a background as a researcher herself, Elizabeth devotes her time to crafting and executing the Association-Wide Research Strategic Plan, steering research teams towards emerging projects, encouraging dialog in fostering bioethics principles, integrating lay stakeholder representation in scientific endeavors, advancing diversity and inclusion initiatives in research operations, and championing anti-harassment awareness and protocols within research and science domains.
	Courtney Ackeifi, PhD Courtney Ackeifi, PhD is a scientist in the Improving Lives program at JDRF, focused on enhancing the lives of individuals with Type 1 Diabetes (T1D). Courtney works to accelerate the development of drugs and devices that enable people with T1D live longer and healthier lives. Before her role at JDRF, Courtney was the Director of Medical and Scientific Affairs at Synapse, a firm specializing in commercialization and communications strategy for the biotech and pharmaceutical industry. As a bench researcher, she focused on regenerative medicine and drug development at Harvard Stem Cell Institute and Mount Sinai. Her thesis and postdoctoral work developed a beta cell regenerative therapy for the treatment of type 1 and type 2 diabetes. Courtney earned a PhD in biophysics and systems pharmacology from the Icahn School of Medicine at Mount Sinai and a BA in biochemistry and music from Wellesley College.

Summary


Availability:	Retired


Cost:	FREE


Credit Offered:	No Credit Offered

Create Account